JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 30 No. 2 240-245
© 1989 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Front, D.
Right arrow Articles by Kolodny, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Front, D.
Right arrow Articles by Kolodny, G. M.

Quantitative Bone Scintigraphy Using SPECT

Dov Front, Ora Israel, Jacqueline Jerushalmi, Alex Frenkel, Galina Iosilevsky, Moshe Feinsod and Gerald M. Kolodny

Departments of Nuclear Medicine and Neurosurgery, Rambam Medical Center and Technion-Israel Institute of Technology, Haifa, Israel
Division of Nuclear Medicine, Department of Radiology, Beth Israel Hospital and Harvard Medical School, Boston

Correspondence: For reprints contact: Dov Front, MD, PhD, Dept. of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel.

ABSTRACT

A quantitative single photon emission computed tomography (SPECT) technique for measuring radiopharmaceutical uptake in humans has been applied to bone scintigraphy. The method was validated by comparing SPECT measured percent of injected [99mTc]MDP in 16 normal skulls with well counter measurements of samples of the same bones obtained at surgery. A very good correlation (r = 0.96) was found. A very good interobserver correlation (r = 0.99) and agreement were also obtained when using quantitative bone scintigraphy (QBS). Control SPECT studies of uptake in the right and left iliac bones and the right and left sacroiliac regions in each patient showed no significant differences between the contralateral sides. Studies done in seven subjects at 2 and 4 hr after the same injection and in nine subjects 4 to 8 mo later in the same subjects showed a very good agreement and no significant differences between the two measurements were found. QBS is suggested as an accurate and reproducible index for assessment of the mass of remodeling bone. Preliminary results showed differences in QBS of normal subjects at different ages. A group of 68 young patients aged 18–26 yr showed a significant higher QBS (p < 0.001) when compared to an older group of 62 patients aged 50–85 yr. There was, however, a wide range of uptake values for the same bone in the same group, suggesting that the method should best be used for following individual patients over time.




This article has been cited by other articles:


Home page
JNMHome page
D. Groshar, G. Slobodin, and E. Zuckerman
Quantitation of Liver and Spleen Uptake of 99mTc-Phytate Colloid Using SPECT: Detection of Liver Cirrhosis
J. Nucl. Med., March 1, 2002; 43(3): 312 - 317.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
O. Israel, Z. Keidar, R. Rubinov, G. Iosilevski, A. Frenkel, A. Kuten, L. Betman, G. M. Kolodny, D. Yarnitsky, and D. Front
Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate
J. Clin. Oncol., July 14, 2000; 18(14): 2747 - 2754.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1989 by the Society of Nuclear Medicine.